BlackRock Investment Management, LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 160 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$4,542,000
-8.7%
459,695
+11.6%
0.01%
-16.7%
Q3 2016$4,975,000
+42.0%
411,838
+1.4%
0.01%
+50.0%
Q2 2016$3,504,000
-0.0%
406,054
+9.7%
0.00%
-20.0%
Q1 2016$3,505,000
-43.1%
370,079
+4.1%
0.01%
-37.5%
Q4 2015$6,161,000
+29.7%
355,507
+0.5%
0.01%
+33.3%
Q3 2015$4,751,000
-41.5%
353,733
-1.6%
0.01%
-40.0%
Q2 2015$8,119,000
+98.8%
359,561
+25.8%
0.01%
+100.0%
Q1 2015$4,083,000
+49.7%
285,925
+1.1%
0.01%
+25.0%
Q4 2014$2,728,000
+5.7%
282,731
-0.3%
0.00%0.0%
Q3 2014$2,582,000
-7.4%
283,706
+0.6%
0.00%0.0%
Q2 2014$2,787,000
-17.6%
282,066
+5.9%
0.00%
-20.0%
Q1 2014$3,383,000
-7.5%
266,258
+9.1%
0.01%0.0%
Q4 2013$3,658,000
+32.8%
244,049
-2.2%
0.01%0.0%
Q3 2013$2,754,000
+46.1%
249,418
+5.2%
0.01%
+66.7%
Q2 2013$1,885,000237,1590.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders